Am J Transplant, Volume 18, Suppl 3 Archives - Page 197 of 211 - ATC Abstracts

2018 American Transplant Congress
Tacrolimus-Based Maintenance Immunosuppression Decreases the Number of Peripheral Blood Transitional B Cells in Nonhuman Primates
J. Paster, K. Pruner, M. Hanekamp, J. O., W. Sommer, K. Robins, A. Bean, G. Benichou, J. Madsen.
Center for Transplantation Sciences, Mass General Hospital, Boston, MA.
IntroductionElevated frequencies of transitional B cells have been reported in patients tolerant of renal allografts, as defined by stable graft function after withdrawal of immunosuppression…
2018 American Transplant Congress
Ex-Situ Normothermic Human Upper Extremity Perfusion: Preliminary Report
V. Fahradyan, E. Dalla Pozza, M. Madajka, K. Cho, N. Dawlagala, E. Duraes, H. Shah, S. Al-deen Said, C. Ordenana, F. Papay, A. Rampazzo, B. Bassiri Gharb.
Plastic Surgery, Cleveland Clinic, Cleveland, OH.
Purpose: Ischemia time remains a significant limiting factor for successful extremity replantation and transplantation. Normothermic ex-situ perfusion is a novel method of a limb preservation…
2018 American Transplant Congress
Molecular Injury and Repair Assessment in Ex Vivo Perfused Swine Heart Transplants
N. Herbers, S. Hatami, P. Dromparis, J. Nagendran, M. Mengel, D. Freed, B. Adam.
University of Alberta, Edmonton, Canada.
Background: Cardiac transplantation is a life-saving intervention for advanced heart failure but it is unfortunately limited by a critical shortage of suitable donor organs and…
2018 American Transplant Congress
Urine Pellet Podocyte mRNAs Correlate Closely with Late Kidney Allograft Loss-of-Function
A. Naik,¹ J. Aqeel,¹ D. Cibrik,² M. Samaniego,¹ M. Chowdhury,¹ S. Wang,¹ F. Afshinnia,¹ R. Wiggins.¹
¹Univ Michigan, Ann Arbor; ²Univ Kansas, Kansas City.
10-year surveillance biopsy studies (Nankivell,2003 & Stegall,2017) and podometric studies are compatible with progressive glomerulosclerosis (GS) contributing to long-term allograft loss-of-function.Thus one would expect to…
2018 American Transplant Congress
Impact of De Novo DSA Development and Management on Kidney Transplant Outcomes
M. Cote,¹ M. Pavlakis,² F. Cardarelli,² J. Pena,³ A. Dinh,³ K. Richards,¹ K. Joyal,¹ C. Rogers.¹
¹Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA; ²Transplant Institute, Beth Israel Deaconess Medical Center, Boston, MA; ³Pathology, Beth Israel Deaconess Medical Center, Boston, MA.
Multiple studies have shown that development of donor specific antibodies (DSAs) can have a negative impact on renal allograft outcomes resulting in decreased renal function,…
2018 American Transplant Congress
Treatment Outcomes of FSGS Recurrence
J. Mansur,¹ D. Chang,² G. Medeiros,¹ M. Cristelli,¹ L. Viana,¹ S. Stopa,¹ C. Felipe,¹ G. Kirsztajn,¹ H. Tedesco-Silva.¹
¹Hospital do Rim, Universidade Federal de Sao Paulo, Sao Paulo, Brazil; ²Hospital Nacional Cayetano Heredia, Universidad Peruana Cayetano Heredia, Lima, Peru.
Background: Recurrence of FSGS (focal segmental glomerulosclerosis) after kidney transplant occurs in 30% of adults and up to 80% of children and has impact on…
2018 American Transplant Congress
Kidney and Liver DCD Outcomes – A Five Year Review
J. Buggs,¹ J. Boone,² M. Adesunkanmi,² R. Mehta,² E. Rogers,³ A. Kumar,⁴ A. Alsina,¹ V. Bowers.¹
¹Transplant Surgery, Tampa General Medical Group, Tampa General Hospital, Tampa, FL; ²Pre-Med Undergraduate, University of South Florida, Tampa, FL; ³Transplant Research, Tampa General Hospital, Tampa, FL; ⁴Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL.
Background: The demand for organ transplantation exceeds the supply and has led to an increase in use of donation after cardiac death (DCD) solid organs…
2018 American Transplant Congress
Microbiology and Outcomes of Febrile Neutropenia Episodes after Kidney Transplant
G. Dube, S. Husain, H. Morris, D. Cohen, S. Mohan.
Medicine, Columbia University Medical Center, New York, NY.
Febrile neutropenia (FN) is a common complication in cancer patients receiving chemotherapy. Neutropenia is common after kidney transplant (KT), but little is known about the…
2018 American Transplant Congress
Outcomes of Renal Transplants from Donors with Positive Blood or Urine Cultures
L. Chen,¹ D. Kamiyama,² L. Francalacci,¹ E. Zhu,² M. Donnelley,² N. Clayton,² K. Alman,¹ A. De Mattos,¹ J. Brown.³
¹Transplant Nephrology, UC Davis Medical Center, Sacramento, CA; ²Pharmacy, UC Davis Medical Center, Sacramento, CA; ³Infectious Diseases, UC Davis Medical Center, Sacramento, CA.
OBJECTIVES: To evaluate outcomes in renal transplant recipients who received organs from donors with positive blood or urine cultures.METHODS: We performed a retrospective, single-center study…
2018 American Transplant Congress
Use of Right or Left Kidneys in Living-Donor Kidney Transplantation. Comparative Study of 320 Cases
M. Perosa,¹ J. Branez,¹ H. Noujaim,¹ L. Mota,¹ B. Zeballos,¹ M. Castro,¹ G. Marchini,¹ L. Ianhez,¹ L. Alvim,¹ D. Machado,¹ C. Watanabe,¹ A. Saldanha,² H. Abensur,² W. Luconi,¹ T. Genzini-Miranda,³ R. Haddad,⁴ T. Genzini.¹
¹Leforte Hospital, Sao Paulo, Brazil; ²Beneficencia Portuguesa Hospital, Sao Paulo, Brazil; ³Medical School, PUC Sorocaba, Sorocaba, Sao Paulo, Brazil; ⁴Medical School, ABC, Sao Paulo, Brazil.
In more than 95% of worldwide living-donor kidney transplants(LDKT), the donor's left kidney (LK) is preferred because of technical difficulties and a shorter vein of…